NCT02232789View on ClinicalTrials.gov

Abuse Liability and Human Pharmacology of Mephedrone

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Amphetamine-Related Disorders
Interventions
DRUG

Mephedrone

Single oral dose mephedrone

DRUG

3,4-methylenedioxymethamphetamine

Single oral dose MDMA

DRUG

Placebo

Single oal dose placebo

Trial Locations (1)

08003

Institut Hospital del Mar d'Investigacions Mèdiques-IMIM. Parc de Salut Mar., Barcelona

All Listed Sponsors
collaborator

Instituto de Salud Carlos III

OTHER_GOV

lead

Parc de Salut Mar

OTHER

NCT02232789 - Abuse Liability and Human Pharmacology of Mephedrone | Biotech Hunter | Biotech Hunter